Stocks / NASDAQ / Mirati Therapeutics, Inc.

Mirati Therapeutics, Inc.

Our Opinion

Mirati Therapeutics is on the Cruelty Free Investing animal use list because the company performs animal testing as part of their research and development.

Company Description

Mirati Therapeutics treats patients with cancer by targeting the genetic changes in tumor cells that result in uncontrolled tumor growth and spread. Their precision oncology strategy seeks to treat the patients most likely to benefit and is driven by drugs that target very specific genetic mutations that cause cancer, and by genomic tests that identify patients who carry those driver mutations.